In an ovarian cancer model, artesunate, a medication used to treat malaria, induced Th1 cell differentiation from CD4+ T cells and showed enhanced proapoptotic effects on ovarian cancer cells by upregulating miR-142 and suppressing SIRT1 levels (88). Here, SIRT1 is linked to ovarian carcinoma.